140 related articles for article (PubMed ID: 20842031)
1. Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.
Capala J; Bouchelouche K
Curr Opin Oncol; 2010 Nov; 22(6):559-66. PubMed ID: 20842031
[TBL] [Abstract][Full Text] [Related]
2. Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer.
Gao F; Liu F; Wang J; Bi J; Zhai L; Li D
J Cancer Res Clin Oncol; 2024 Mar; 150(3):118. PubMed ID: 38466436
[TBL] [Abstract][Full Text] [Related]
3. Targeting HER2 in Nuclear Medicine for Imaging and Therapy.
Massicano AVF; Marquez-Nostra BV; Lapi SE
Mol Imaging; 2018; 17():1536012117745386. PubMed ID: 29357745
[TBL] [Abstract][Full Text] [Related]
4. First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.
Sörensen J; Sandberg D; Sandström M; Wennborg A; Feldwisch J; Tolmachev V; Åström G; Lubberink M; Garske-Román U; Carlsson J; Lindman H
J Nucl Med; 2014 May; 55(5):730-5. PubMed ID: 24665085
[TBL] [Abstract][Full Text] [Related]
5. Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer.
Goldstein R; Sosabowski J; Vigor K; Chester K; Meyer T
Expert Rev Anticancer Ther; 2013 Mar; 13(3):359-73. PubMed ID: 23477521
[TBL] [Abstract][Full Text] [Related]
6. Phase II Trial Assessing the Repeatability and Tumor Uptake of [
Gondry O; Caveliers V; Xavier C; Raes L; Vanhoeij M; Verfaillie G; Fontaine C; Glorieus K; De Grève J; Joris S; Luyten I; Zwaenepoel K; Vandenbroucke F; Waelput W; Thyparambil S; Vaneycken I; Cousaert J; Bourgeois S; Devoogdt N; Goethals L; Everaert H; De Geeter F; Lahoutte T; Keyaerts M
J Nucl Med; 2024 Feb; 65(2):178-184. PubMed ID: 38302159
[TBL] [Abstract][Full Text] [Related]
7. Homodimer
Ebrahimi F; Noaparast Z; Abedi SM; Hosseinimehr SJ
Med Oncol; 2022 Sep; 39(12):204. PubMed ID: 36175805
[TBL] [Abstract][Full Text] [Related]
8. Novel applications of molecular imaging to guide breast cancer therapy.
Edmonds CE; O'Brien SR; Mankoff DA; Pantel AR
Cancer Imaging; 2022 Jun; 22(1):31. PubMed ID: 35729608
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeled Antibodies for Cancer Imaging and Therapy.
Parakh S; Lee ST; Gan HK; Scott AM
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326605
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive comparison between camelid nanobodies and single chain variable fragments.
Asaadi Y; Jouneghani FF; Janani S; Rahbarizadeh F
Biomark Res; 2021 Dec; 9(1):87. PubMed ID: 34863296
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide-Based Imaging of Breast Cancer: State of the Art.
Li H; Liu Z; Yuan L; Fan K; Zhang Y; Cai W; Lan X
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771622
[TBL] [Abstract][Full Text] [Related]
12. Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies.
Hrynchak I; Santos L; Falcão A; Gomes CM; Abrunhosa AJ
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639086
[TBL] [Abstract][Full Text] [Related]
13. Dual Function Antibody Conjugates for Multimodal Imaging and Photoimmunotherapy of Cancer Cells.
Saad MA; Xavierselvan M; Sharif HA; Selfridge S; Pawle R; Varvares M; Mallidi S; Hasan T
Photochem Photobiol; 2022 Jan; 98(1):220-231. PubMed ID: 34379796
[TBL] [Abstract][Full Text] [Related]
14. Labeling single domain antibody fragments with
Zhou Z; McDougald D; Meshaw R; Balyasnikova I; Zalutsky MR; Vaidyanathan G
Nucl Med Biol; 2021; 100-101():24-35. PubMed ID: 34146837
[TBL] [Abstract][Full Text] [Related]
15. Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.
Okarvi SM; AlJammaz I
Molecules; 2019 Aug; 24(17):. PubMed ID: 31470531
[TBL] [Abstract][Full Text] [Related]
16. Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer.
Schillaci O; Scimeca M; Toschi N; Bonfiglio R; Urbano N; Bonanno E
Contrast Media Mol Imaging; 2019; 2019():9429761. PubMed ID: 31354394
[TBL] [Abstract][Full Text] [Related]
17.
Pitalúa-Cortés QG; García-Pérez FO; Villaseñor-Navarro Y; Lara-Medina FU; Matus-Santos JA; Soldevilla-Gallardo I; Porras-Reyes FI; Pérez-Sánchez VM; Maldonado-Martínez HA; Pérez-Báez W; Sollozo-Dupont I
BJR Case Rep; 2017; 3(3):20160136. PubMed ID: 30363270
[TBL] [Abstract][Full Text] [Related]
18. Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer.
Henry KE; Ulaner GA; Lewis JS
PET Clin; 2018 Jul; 13(3):423-435. PubMed ID: 30100080
[TBL] [Abstract][Full Text] [Related]
19. Dedicated Breast Gamma Camera Imaging and Breast PET: Current Status and Future Directions.
Narayanan D; Berg WA
PET Clin; 2018 Jul; 13(3):363-381. PubMed ID: 30100076
[TBL] [Abstract][Full Text] [Related]
20. Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging.
Tang L; Peng C; Tang B; Li Z; Wang X; Li J; Gao F; Huang L; Xu D; Zhang P; Zhuang R; Su X; Chen X; Zhang X
J Nucl Med; 2018 Sep; 59(9):1386-1391. PubMed ID: 29653973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
